These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 4005859

  • 1. Presence of breast cancer antigens in uninvolved axillary lymph nodes.
    Hendler FJ, House D.
    Cancer Res; 1985 Jul; 45(7):3364-73. PubMed ID: 4005859
    [Abstract] [Full Text] [Related]

  • 2. Relationship of monoclonal antibody binding to estrogen and progesterone receptor content in breast cancer.
    Hendler FJ, Yuan D.
    Cancer Res; 1985 Jan; 45(1):421-9. PubMed ID: 3965148
    [Abstract] [Full Text] [Related]

  • 3. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
    Nuti M, Castagna M, Squartini F.
    Appl Pathol; 1984 Jan; 2(3):117-27. PubMed ID: 6085790
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR, Romero AO, Pérez JE, Lacava JA, Domínguez ME, Rodríguez R, Barbieri MR, Romero Acuña LA, Romero Acuña JM, Langhi MJ, Amato S, Ortiz EH, Vallejo CT, Leone BA.
    Cancer J Sci Am; 1998 Jan; 4(2):125-31. PubMed ID: 9554929
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
    Morton BA, Ramey WG, Paderon H, Miller RE.
    Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
    Edwards DP, Grzyb KT, Dressler LG, Mansel RE, Zava DT, Sledge GW, McGuire WL.
    Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Production and characterization of monoclonal antibodies showing a different spectrum of reactivity to human breast tissue.
    Mandeville R, Giroux L, Lecomte J, Chausseau JP, Dumas F, Ajdukovic I, Vidal D, Boury F.
    Cancer Detect Prev; 1987 Mar; 10(1-2):89-100. PubMed ID: 2436777
    [Abstract] [Full Text] [Related]

  • 10. [Identification of the sentinel node in patients with breast carcinoma].
    Nieweg OE, Kapteijn BA, Peterse JL, Rutgers EJ, van Dongen JA, Kroon BB.
    Ned Tijdschr Geneeskd; 1996 Nov 09; 140(45):2235-9. PubMed ID: 8984369
    [Abstract] [Full Text] [Related]

  • 11. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
    Ahmad Z, Khurshid A, Qureshi A, Idress R, Asghar N, Kayani N.
    Indian J Pathol Microbiol; 2009 Nov 09; 52(4):477-81. PubMed ID: 19805950
    [Abstract] [Full Text] [Related]

  • 12. Human-human hybridomas and human monoclonal antibodies obtained by fusion of lymph node lymphocytes from breast cancer patients.
    Kjeldsen TB, Rasmussen BB, Rose C, Zeuthen J.
    Cancer Res; 1988 Jun 01; 48(11):3208-14. PubMed ID: 3365703
    [Abstract] [Full Text] [Related]

  • 13. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.
    J Surg Oncol; 2004 Mar 01; 85(3):102-11. PubMed ID: 14991881
    [Abstract] [Full Text] [Related]

  • 14. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
    Gebauer G, Fehm T, Merkle E, Jaeger W, Mitze M.
    Anticancer Res; 2003 Mar 01; 23(5b):4319-24. PubMed ID: 14666645
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A, Guray M, Hennessy BT, Middleton LP, Buchholz TA, Valero V, Sahin AA.
    Cancer; 2009 Apr 15; 115(8):1605-12. PubMed ID: 19197997
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.